Arterial blood pressure is reduced by halothane, primarily by decreases in myocardial contractility and cardiac output.
Heart rate is unchanged by halothane.
In addition, halothane also inhibits the baroreceptor-increased heart rate usually seen with lowered blood pressure. Stroke volume is reduced and is consistent with decreased myocardial contractility. Patients with impaired contractility secondary to congestive heart failure are particularly vulnerable to inhaled anesthetics. Systemic vascular resistance is unchanged, but halothane does have venodilating effects and increases skin blood flow. All volatile anesthetics increase cerebral blood flow, with halothane having the greatest effect.